Literature DB >> 9486250

Mechanism of lidocaine block of late current in long Q-T mutant Na+ channels.

R Dumaine1, G E Kirsch.   

Abstract

Inherited long Q-T syndrome is a ventricular arrhythmia associated with delayed repolarization and the risk of sudden death. The chromosome 3-linked form of the disease (LQT3) is associated with mutations in the cardiac Na+ channel (N1325S or R1644H; or deletion of residues 1,505-1,507, delta KPQ) that increase late inward currents and may cause delayed repolarization. Late currents arise from dispersed reopenings (N1325S and R1644H) or from reopenings combined with prolonged bursts (delta KPQ). Therefore, we tested whether lidocaine blockade of late current varied among the different LQT3 mutant channels. We found that lidocaine preferentially blocked late over peak current and that the blockade was equally effective in all three channels, expressed in Xenopus oocytes. Lidocaine inhibited both dispersed reopenings and bursting in single channels without affecting mean open times. In the absence of drug, inactivating prepulses inhibited bursting but not dispersed reopenings. We suggest that lidocaine block of late current in LQT3 channels acts via a common mechanism involving stabilization of inactivation. Therefore, blockers that target the inactivated state may be effective therapeutic agents in all three biophysical phenotypes of LQT3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486250     DOI: 10.1152/ajpheart.1998.274.2.H477

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Probing kinetic drug binding mechanism in voltage-gated sodium ion channel: open state versus inactive state blockers.

Authors:  Krishnendu Pal; Gautam Gangopadhyay
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

2.  The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity.

Authors:  Weihua Song; Yucheng Xiao; Hanying Chen; Nicole M Ashpole; Andrew D Piekarz; Peilin Ma; Andy Hudmon; Theodore R Cummins; Weinian Shou
Journal:  J Physiol       Date:  2012-07-23       Impact factor: 5.182

Review 3.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Utility of a simplified lidocaine and potassium infusion in diagnosing long QT syndrome among patients with borderline QTc interval prolongation.

Authors:  Vijay S Chauhan; Andrew D Krahn; George J Klein; Allan C Skanes; Raymond Yee
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

5.  Use-dependent block of cardiac late Na(+) current by ranolazine.

Authors:  Sridharan Rajamani; Nesrine El-Bizri; John C Shryock; Jonathan C Makielski; Luiz Belardinelli
Journal:  Heart Rhythm       Date:  2009-07-28       Impact factor: 6.343

6.  Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.

Authors:  Jonathan D Moreno; Pei-Chi Yang; John R Bankston; Eleonora Grandi; Donald M Bers; Robert S Kass; Colleen E Clancy
Journal:  Circ Res       Date:  2013-07-29       Impact factor: 17.367

7.  Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.

Authors:  Sandra Fredj; Kevin J Sampson; Huajun Liu; Robert S Kass
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

8.  Modulation of canine cardiac sodium current by Apelin.

Authors:  Caroline Chamberland; Hector Barajas-Martinez; Volker Haufe; Marie-Hélène Fecteau; Jean-Francois Delabre; Alexander Burashnikov; Charles Antzelevitch; Olivier Lesur; Ahmed Chraibi; Philippe Sarret; Robert Dumaine
Journal:  J Mol Cell Cardiol       Date:  2009-12-28       Impact factor: 5.000

9.  Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.

Authors:  J F Desaphy; D Conte Camerino; C Franchini; G Lentini; V Tortorella; A De Luca
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

10.  Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues.

Authors:  Huajun Liu; Joshua Atkins; Robert S Kass
Journal:  J Gen Physiol       Date:  2003-03       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.